ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,414Medicare Part D Prescriptions Filled, Including Refills

Rank: 156 out of 5176

$1.76M Total Retail Price of All Prescriptions

Rank: 74 out of 5176

349 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
100% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 349 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 16,390 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

54% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$101 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

50 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
NEXIUM 781 775 1 16
CRESTOR 585 552 2 15
SIMVASTATIN 451 442 3 1
PLAVIX 423 414 4 29
METOPROLOL SUCCINATE 413 393 5 11
AMLODIPINE BESYLATE 392 375 6 2
ZOLPIDEM TARTRATE 391 373 7 17
METOPROLOL TARTRATE 390 372 8 6
LIDODERM 378 376 9 59
LOVAZA 271 268 10 43
LOSARTAN-HYDROCHLOROTHIAZIDE 263 250 11 35
CREON 260 253 12 111
OMEPRAZOLE 253 222 13 3
METFORMIN HCL 243 214 14 7
CLOPIDOGREL 239 220 15 26
ADVAIR DISKUS 229 207 16 32
LOSARTAN POTASSIUM 227 193 17 14
CARVEDILOL 218 210 18 24
DIOVAN 216 216 19 19
DIOVAN HCT 213 207 20 39
ATORVASTATIN CALCIUM 210 195 21 9
COUMADIN 195 195 22 112
FUROSEMIDE 185 173 23 8
CELEBREX 183 183 24 80
MECLIZINE HCL 177 168 25 81
SYNTHROID 170 155 26 33
ENALAPRIL MALEATE 158 146 27 22
SPIRIVA 157 136 28 54
JANUVIA 155 142 29 25
AMMONIUM LACTATE 150 143 30 91
ZETIA 143 138 31 68
SINGULAIR 143 138 31 62
FLUTICASONE PROPIONATE 140 130 33 38
LISINOPRIL 137 122 34 5
ENALAPRIL-HYDROCHLOROTHIAZIDE 132 126 35 212
BENICAR HCT 132 131 35 110
LIPITOR 128 128 37 51
AZITHROMYCIN 121 113 38 42
RANITIDINE HCL 121 118 38 36
NAMENDA 114 114 40 47
BENICAR 113 112 41 100
TRAMADOL HCL 113 102 41 40
VOLTAREN 112 112 43 97
SOLARAZE 109 108 44 157
ATENOLOL 108 99 45 12
JANUMET 108 104 45 77
PROAIR HFA 105 103 47 60
NITROGLYCERIN PATCH 102 99 48 149
VENTOLIN HFA 95 75 49 64
DEXILANT 92 84 50 118
SYMBICORT 88 75 51 120
GLYBURIDE-METFORMIN HCL 88 79 R 51 76
GLIMEPIRIDE 88 73 51 37
PROCTOZONE-HC 87 81 54 171
WARFARIN SODIUM 85 77 55 13
ISOSORBIDE MONONITRATE ER 84 77 56 44
LANSOPRAZOLE 83 81 57 113
RAMIPRIL 83 83 57 50
HYDROCHLOROTHIAZIDE 82 82 59 10
ALENDRONATE SODIUM 80 73 60 18
MELOXICAM 79 76 61 53
ACTOS 77 73 62 85
ALLOPURINOL 76 58 63 41
GABAPENTIN 74 59 64 21
IBUPROFEN 74 70 64 72
PATANOL 74 69 64 158
RANEXA 73 73 67 167
TAMSULOSIN HCL 73 73 67 20
PROPRANOLOL HCL 69 69 69 199
AMLODIPINE BESYLATE-BENAZEPRIL 69 69 69 55
VYTORIN 68 61 71 152
SERTRALINE HCL 67 60 72 30
DICYCLOMINE HCL 66 66 73 224
DONEPEZIL HCL 64 64 74 28
EVISTA 63 63 75 65
LEXAPRO 61 61 76 193
LIDOCAINE 59 50 77 179
TEKTURNA 59 49 77 255
PANTOPRAZOLE SODIUM 58 58 79 61
LYRICA 57 49 80 133
CHLORHEXIDINE GLUCONATE 56 56 81 202
TRICOR 55 42 82 148
VENLAFAXINE HCL ER 55 55 82 186
CLOTRIMAZOLE-BETAMETHASONE 55 53 82 94
LEVOTHYROXINE SODIUM 54 54 85 4
SINGLE USE SWAB 53 49 86 108
TRAMADOL HCL-ACETAMINOPHEN 53 48 86 116
LUNESTA 52 48 88 242
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.